Michael joined Sofinnova Partners in 2013 and is a partner in the Industrial Biotech Strategy. His primary focus is on identifying early-stage deals in Europe and North America with applications ranging from chemicals, materials, agriculture, food, feed, and synthetic biology.
In addition to being a board member of Afyren, Michael is or has been on the board of directors of Elicit Plant, Meiogenix, EnginZyme, Comet Bio, and EnobraQ. He also served for 2 years as the CEO of EnobraQ, a Sofinnova Partners鈥� Green Seed Fund portfolio company.
Before joining Sofinnova, Michael spent six years in industrial biotech start-ups, in senior business development roles. He also worked in a consulting firm advising companies on strategic R&D and organizational issues. Michael is an engineer who graduated from Ecole Polytechnique in Paris and holds a Ph.D. in organic chemistry from Paris X Orsay University.